glp-1 gastrointestinal obstruction legal team in west virginia law firm Zepbound Lawsuit [2026] Frontiers | Dissecting the Physiology

Evelyn Attia, MD, director of the Center for Eating Disorders at NewYork-Presbyterian, says people whove struggled with eating disorders or restrictive dieting should avoid taking GLP-1s

She says roughly half of those who take GLP-1 drugs lose 15% or more of their weight, and "because the potential of those drugs is so incredible for that half, everyone who takes them thinks they're going to be in the half that have that experience." Manne-Goehler says what's often forgotten is that obesity is a chronic, lifelong condition

Medication, nutrition, and exercise should work together

Semaglutide (Ozempic/Wegovy) Semaglutide offers proven weight loss results with slightly better insurance coverage than Tirzepatide

Research consistently shows that a significant portion of lost weight is regained when treatment is stopped